Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Employment and multiple sclerosis in new zealand.
Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?
Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.
Are PrP(C)s involved in some human myelin diseases? Relating experimental studies to human pathology.
Interferon treatment of multiple sclerosis.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
Correlates of participation in meaningful activities among people with multiple sclerosis.
Plasma Exchange and Immunoadsorption in Pediatric Inflammatory Optic Neuropathy Resistant to Corticosteroid Therapy: Four French Cases.
Erratum to: Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
Stress as provoking factor for the first and repeated multiple sclerosis seizures.
A critical role for interleukin-1β in the progression of autoimmune diseases.
A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis.
Synaptic plasticity in multiple sclerosis and in experimental autoimmune encephalomyelitis.
Acid-Sensing Ion Channels Contribute to Neurotoxicity.
Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: A proposed method for imaging subpial demyelination.
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
A Novel MPZ Gene Mutation in Exon 2 Causing Late-Onset Demyelinating Charcot-Marie-Tooth Disease.
Multiple sclerosis.
A case of multiple sclerosis with bilateral intermediate uveitis.
We-Measure: Toward a low-cost portable posturography for patients with multiple sclerosis using the commercial Wii balance board.
Pharmacology and Structure of P2Y Receptors.
Myelin oligodendrocyte glycoprotein (MOG35-55)-induced experimental autoimmune encephalomyelitis is ameliorated in interleukin-32 alpha transgenic mice.
Is disability pension a risk indicator for future need of psychiatric healthcare or suicidal behavior among MS patients- a nationwide register study in Sweden?
Glial influences on BBB functions and molecular players in immune cell trafficking.
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases.
Pages
« first
‹ previous
…
642
643
644
645
646
647
648
649
650
…
next ›
last »